Page last updated: 2024-11-06

benzimidazole and Colorectal Neoplasms

benzimidazole has been researched along with Colorectal Neoplasms in 2 studies

1H-benzimidazole : The 1H-tautomer of benzimidazole.

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Tan, YJ1
Lee, YT1
Mancera, RL1
Oon, CE1
He, LJ1
Yang, DL1
Li, SQ1
Zhang, YJ1
Tang, Y1
Lei, J1
Frett, B1
Lin, HK1
Li, HY1
Chen, ZZ1
Xu, ZG1

Other Studies

2 other studies available for benzimidazole and Colorectal Neoplasms

ArticleYear
BZD9L1 sirtuin inhibitor: Identification of key molecular targets and their biological functions in HCT 116 colorectal cancer cells.
    Life sciences, 2021, Nov-01, Volume: 284

    Topics: Apoptosis; Benzimidazoles; Cell Adhesion; Cell Polarity; Colorectal Neoplasms; Gene Expression Regul

2021
Facile construction of fused benzimidazole-isoquinolinones that induce cell-cycle arrest and apoptosis in colorectal cancer cells.
    Bioorganic & medicinal chemistry, 2018, 08-07, Volume: 26, Issue:14

    Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Pro

2018